Cameroon vs Fiji: Treatment coverage for lymphatic filariasis
Cameroon
33.8%
in 2021
Fiji
41.7%
in 2023
Cameroon rank
46th
Fiji rank
43rd
Treatment coverage for lymphatic filariasis over time
- Cameroon
- Fiji
How they compare
Fiji currently reports 41.7% against 33.8% in Cameroon, a difference of 7.9%.
That makes Fiji's figure about 1.2 times Cameroon's.
The two have swapped places 5 times across 14 shared years of data; in 2008 it was Fiji ahead.
Cameroon ranks 46th and Fiji ranks 43rd of 66 countries.
Across the 3 decades both report, Cameroon averaged higher in 1 and Fiji in 2.
Head to head by decade
| Decade | Cameroon | Fiji | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.2% | 46.0% | 39.8% | Fiji |
| 2010s | 52.5% | 64.1% | 11.6% | Fiji |
| 2020s | 16.9% | 9.7% | 7.2% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for lymphatic filariasis, Cameroon or Fiji?
- Fiji, at 41.7% against 33.8% in Cameroon as of 2023.
- What is the difference in treatment coverage for lymphatic filariasis between Cameroon and Fiji?
- 7.9%, with Fiji ahead.
- How many years of comparable data are there for Cameroon and Fiji?
- 14 years are reported by both, from 2008 to 2021.
- How do Cameroon and Fiji rank globally for treatment coverage for lymphatic filariasis?
- Cameroon ranks 46th and Fiji ranks 43rd of 66 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Treatment coverage for lymphatic filariasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.